Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
337
mentions
- X 216
- News 72
- Facebook 27
- Blogs 17
- +2 more
Christopher P Cannon
PubHawk tracks social media discussions for 8 articles by authors named Christopher P Cannon.
Mentions
1,421
Peak: 106 in Oct 2024
across 8 tracked articles
Extended reach
4,947,351
potential audience
Total likes
3,269
Video views
83,891
Mentions per month
Jun 2015 – Oct 2025Where it's discussed
-
X / Twitter952 posts
-
News252 articles
-
Facebook139 posts
-
Blogs53 articles
-
YouTube24 videos
-
Bluesky1 posts
Tracked by PubHawk
Most discussed articles
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
255
mentions
- X 205
- Facebook 29
- News 8
- Blogs 8
- +1 more
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
218
mentions
- X 167
- News 35
- Blogs 8
- YouTube 4
- +1 more
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
210
mentions
- X 87
- Facebook 59
- News 53
- Blogs 9
- +1 more
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
140
mentions
- News 75
- X 38
- Facebook 12
- Blogs 11
- +1 more
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.
115
mentions
- X 107
- Facebook 3
- News 3
- YouTube 2
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.
115
mentions
- X 107
- Facebook 3
- News 3
- YouTube 2
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD Registry.
31
mentions
- X 25
- News 3
- Facebook 2
- YouTube 1
From PubMed
All publications
Searching PubMed…